Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 273 No 7309 p107
24 July 2004

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Information access still lacking in developing world

Access to information for most health professionals working in the developing world has not improved in the past 10 years despite the revolution in information technology, researchers revealed last week.

Where progress has been made it has been patchy, with sub-Saharan Africa “falling far behind” most other regions.

The international researchers recommend that the World Health Organization should be given the authority to “champion” the progress of IT information sharing among health professionals so that by 2015 there is universal access to information.

The researchers say: “Despite the promises of the information revolution and some successful initiatives, there is little if any evidence that the majority of health professionals in the developing world are any better informed than they were 10 years ago.”

Some health professionals in the developing world, for example, those working in tertiary hospitals and academic institutions and those in urban areas, now have access to more and better quality information than they did 10 years ago. However, this is in stark contrast to health professionals in primary care where there is little evidence that there have been any improvements in the past decade.

Lack of internet access or an online connection that is slow or unreliable as well as the high costs of using the internet and computer paper were the major barriers to helping improve knowledge-based health care in the developing world. The current health information IT system is failing because it is under-resourced, unmanaged and poorly understood, they add (Lancet 2004;364:295).

Nigel Cox, pharmacy systems development executive for the National Pharmaceutical Association, said: “I think one of the biggest problems is that the necessary infrastructure does not exist in the majority of developing or underdeveloped countries.”

Back to Top


©The Pharmaceutical Journal